Minamestane
Minamestane (FCE 24928) is a selective and competitive aromatase inhibitor with an IC50 value of 45.7 nM. Minamestane is promising for research of postmenopausal breast cancer[1].
Product Specifications
CAS Number
105051-87-4
Product Name Alternative
FCE 24928
UNSPSC
12352211
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/minamestane.html
Smiles
C[C@@]12[C@]3([H])[C@](C=CC1=C(C(C=C2)=O)N)([H])[C@@]4([H])[C@](CC3)(C(CC4)=O)C
Molecular Formula
C19H23NO2
Molecular Weight
297.39
References & Citations
[1]Di Salle E, et al. Novel aromatase and 5α-reductase inhibitors[J]. The Journal of Steroid Biochemistry and Molecular Biology, 1994, 49 (4-6) : 289-294.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG237868 10 µg
Synaptotagmin V (SYT5) (NM_001297774) Human Tagged ORF Clone
Sign In for Pricing
View Details 
